Tahoe Therapeutics, Inc.
- Biotech or pharma, therapeutic R&D
Tahoe Therapeutics (formerly Vevo Therapeutics) is transforming oncology R&D with the Mosaic Platform and Tahoe-100M—the world’s largest single-cell perturbation dataset—enabling AI-first drug discovery across all solid tumor types.
We’re partnering:
1) With top biopharma on large-scale drug, genetic, and phenotypic perturbation data generation deals
2) Seeking collaborators to co-develop or license >10 validated tumor-specific surface targets for ADCs, BiTEs, radioligands, and TCR Mimetics.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}